Ingmar Schön: Our paper on Thrombin-Driven Regulation of Platelet Contractility Is Now Live
Ingmar Schön, Senior Lecturer at Royal College of Surgeons in Ireland, shared on LinkedIn about a recent article he and his colleagues co-authored, published in Blood Advances, adding:
”Right about now, the funk soul brother check it out now – our newest paper in Blood Advances has been published in its final style!
It’s been a long and winding road that Dishon Wayne Hiebner, PhD had started down five years ago, joined by Smita Patil, PhD and Martin Kenny, PhD in my lab.
They discovered that the clotting enzyme thrombin boosts platelet contraction in a unique manner, through short-term PAR>G13>RhoA>Rock>pMLC signalling that may be sustained long-term by up-regulation on the RNA/protein levels.
Our data also suggest that thrombin might be a critical driver of clot contraction when platelets have been treated with anti-platelet drugs.
Overall, our study showed that thrombin fuels the heavy lifting performed by platelets during clot formation.
It’s an honour that our article has been highlighted in a commentary by Molly Mollica, Ph.D. who highlighted the wider research context.
You never walk alone – we say a huge ‘thank you’ to Markus Bender and Viola Vogel and their teams for their important contributions and a fruitful collaboration.
It’s also great to see how our undergraduate research students Fionnuala Mullin and Sarah Benn have played their parts in collecting the data.
Last but not least, I am grateful for funding from Research Ireland (SFI) and their support in managing the project through (post-)Covid times, and my RCSI School of Pharmacy and Biomolecular Sciences for their support too.”
Title: Regulation of platelet contractility by agonists present across a thrombus
Authors: Dishon W. Hiebner, Smita Patil, Martin Kenny, Juliane Baumann, Fionnuala Mullin, Sarah Benn, Sebastian Lickert, Viola Vogel, Markus Bender, Ingmar Schoen

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 20, 2026, 12:29Thirunavukkarasu Angappan: Antithrombin in ECMO – Two Datasets, Two Opposite Answers
-
Nov 20, 2026, 11:38Muhammad Kashif: Therapeutic Plasma Exchange – Key Concepts at a Glance
-
Nov 20, 2026, 11:33Tyler McConville: Why Hemostatic Function Matters More Than Cell Counts in Trauma and Transfusion
-
Nov 20, 2026, 11:28Stéphanie Forté: Bringing Cutting-Edge Genomic and Proteomic Tools to Sickle Cell Disease Patients
-
Nov 20, 2026, 11:19EHC Urges Equal Early Diagnosis for Bleeding Disorders
-
Nov 20, 2026, 11:14Pushpinder Singh: How Do We Know if Haemodialysis is Effective?
-
Nov 20, 2026, 11:09Neel Patel: Honoured to Serve Across Five Faculty Roles at Hematocon 2026
-
Nov 20, 2026, 11:03Alok Khorana: First FXI Inhibitor Approved in the US
-
Nov 20, 2026, 06:51How YERM Shapes the Careers of Future Hematology Researchers – EHA